Metabolism of flavonoids via enteric recycling: Mechanistic studies of disposition of apigenin in the Caco-2 cell culture model

被引:123
作者
Hu, M [1 ]
Chen, J [1 ]
Lin, HM [1 ]
机构
[1] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Pullman, WA 99164 USA
关键词
D O I
10.1124/jpet.103.053496
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to determine the mechanisms responsible for intestinal disposition of apigenin in the human Caco-2 cell culture model. The results indicated that most of the absorbed apigenin (10 muM) were conjugated and only a small fraction was transported intact. The amounts of conjugates excreted, especially that of the sulfate, were dependent on days-post-seeding. Apical efflux of apigenin sulfate did not change with concentration of apigenin (4 to 40 muM), whereas its basolateral efflux increased (p < 0.01) with concentration and plateaued at about 25 μM. In contrast, sulfate formation rates in cell lysate increased with concentration and plateaued at 25 μM and were 4 to 6 times faster than the corresponding excretion rates. Formation and polarized excretion rates of glucuronidated apigenin increased with apigenin concentration but formation rates were usually 2.5 to 6 times faster than the corresponding excretion rates. Inhibitors of multidrug resistance-related proteins (MRPs) such as leukotriene C-4 and MK-571, which inhibited glucuronidation of apigenin at a high concentration (≥25 μM), significantly decreased excretion of both apigenin conjugates, and higher concentrations of MK-571 increased the extent of inhibition. In contrast, an organic anion transporter (OAT) inhibitor estrone sulfate only inhibited excretion of apigenin sulfate. In conclusion, we have shown for the first time that intestinal efflux is the rate-limiting step in the intestinal excretion of phase II conjugates of flavones. Furthermore, MRP and OAT are involved in the intestinal efflux of these hydrophilic phase II conjugates.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 28 条
[1]   Isoflavones from Tofu are absorbed and metabolized in the isolated rat small intestine [J].
Andlauer, W ;
Kolb, J ;
Fürst, P .
JOURNAL OF NUTRITION, 2000, 130 (12) :3021-3027
[2]   Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[3]   Metabolism of flavonoids via enteric recycling: Role of intestinal disposition [J].
Chen, J ;
Lin, HM ;
Hu, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (03) :1228-1235
[4]   Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen [J].
Crespy, V ;
Morand, C ;
Manach, C ;
Besson, C ;
Demigne, C ;
Remesy, C .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 277 (01) :G120-G126
[5]   Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells [J].
Galijatovic, A ;
Otake, Y ;
Walle, UK ;
Walle, T .
XENOBIOTICA, 1999, 29 (12) :1241-1256
[6]  
Gotoh Y, 2000, J PHARMACOL EXP THER, V292, P433
[7]   Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells [J].
Gupta, S ;
Afaq, F ;
Mukhtar, H .
ONCOGENE, 2002, 21 (23) :3727-3738
[8]   Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells [J].
Gupta, S ;
Afaq, F ;
Mukhtar, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (04) :914-920
[9]   Advances in flavonoid research since 1992 [J].
Harborne, JB ;
Williams, CA .
PHYTOCHEMISTRY, 2000, 55 (06) :481-504
[10]   Peptide transporter function and prolidase activities in Caco-2 cells: A lack of coordinated expression [J].
Hu, M ;
Zheng, LX ;
Chen, JY ;
Liu, LJ ;
Li, YQ ;
Dantzig, AH ;
Stratford, RE .
JOURNAL OF DRUG TARGETING, 1995, 3 (04) :291-300